JOB DESCRIPTION: About Abbott At Abbott, were committed to helping people live their best possible life through the power of health. For more than 125 years, weve brought new products and technologies to the world —
Job Description We zijn op zoek naar een gemotiveerde masterstudent Farmacie of Life Sciences! Wil je graag weten hoe het is om deel uit te maken van een van de grootste internationale bedrijven in de farmaceutische
Company Overview Verathon is a global medical device company focused on supporting customers by being their trusted partner, delivering high-quality products that endure over time and ensure clinical and economic utility. Two areas where Verathon has
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our
Job Description We are looking for a motivated fourth year of a Master’s degree in Pharmacy student! Do you want to know what its like to be part of one of the largest multinational companies in
Job Description . Skills) Job Description In Primary Posting Language (Include Requirements For Education, Experience And Skills) Wat je hier maakt, gaat de wereld over! Draag bij aan innovatieve vaccins die het welzijn van dieren verbeteren
Job Description Welcome to the team At our company, we are committed to delivering innovative solutions that make a meaningful difference for patients and customers around the world. Within Global Engineering Solutions, our Packaging Technology team
Job Description Wil jij een team en jezelf ontwikkelen in een dynamische, internationale farmaceutische productieomgeving, waarin geen dag hetzelfde is? Solliciteer dan direct! Voor onze business unit Vaccines zoeken we een: Manager Operations Welkom in ons
Company Overview We are partnering with a late-stage biopharmaceutical company developing a first-in-class therapy for cardio-metabolic disease, targeting the intersection of metabolic dysfunction and cardiovascular risk. With its lead asset advancing into Phase 3 development, the